Cancer Control Act
2023-04-26
手機睡眠
語音選擇
Article 1
This Act is enacted to integrate and utilize health and medical care resources for the effective promotion of cancer prevention and to protect the health of the population and to alleviate the threat of cancer.
Article 2
The term "competent authority" as used in this Act refers to:
1. the Ministry of Health and Welfare at the central level;
2. the municipal government at the special municipality level; and
3. the county (city) government at the county (city) level.
1. the Ministry of Health and Welfare at the central level;
2. the municipal government at the special municipality level; and
3. the county (city) government at the county (city) level.
Article 3
Terms used in this Act are defined as follows:
1. "Cancer": Malignant tumors confirmed by pathological
examination, or presumptively diagnosed through other
effective examinations or tests, that are clinically characterized by
recurrence or metastasis.
2. "Cancer screening": The process of identifying
individuals who may or may not have cancer through examinations,
testing, or other diagnostic methods.
1. "Cancer": Malignant tumors confirmed by pathological
examination, or presumptively diagnosed through other
effective examinations or tests, that are clinically characterized by
recurrence or metastasis.
2. "Cancer screening": The process of identifying
individuals who may or may not have cancer through examinations,
testing, or other diagnostic methods.
Article 4
Cancer prevention and control under this Act includes the following:
1. Promoting cancer prevention education and related preventive measures;
2. Providing cost-effective cancer screening services;
3. Delivering accurate, patient-centered medical care, appropriate treatment, and follow-up plans for cancer patients;
4. Providing palliative care for terminal cancer patients;
5. Conducting research related to cancer prevention and control;
6. Establishing cancer-related databases;
7. Providing education and training for medical personnel involved in cancer prevention and control;
8. Other matters related to cancer prevention, diagnosis, treatment, and care.
1. Promoting cancer prevention education and related preventive measures;
2. Providing cost-effective cancer screening services;
3. Delivering accurate, patient-centered medical care, appropriate treatment, and follow-up plans for cancer patients;
4. Providing palliative care for terminal cancer patients;
5. Conducting research related to cancer prevention and control;
6. Establishing cancer-related databases;
7. Providing education and training for medical personnel involved in cancer prevention and control;
8. Other matters related to cancer prevention, diagnosis, treatment, and care.
Article 5
The State shall allocate sufficient resources and integrate efforts from both the public and private sectors to promote advanced medical technology research, support clinical trials, and advance cancer control efforts. Knowledge of cancer prevention and appropriate medical care for
cancer patients shall be incorporated into national compulsory education. The State shall also strive to reduce public exposure to carcinogenic risk factors.
cancer patients shall be incorporated into national compulsory education. The State shall also strive to reduce public exposure to carcinogenic risk factors.
Article 6
To implement cancer control policy, the Executive Yuan shall establish the Central Cancer Control Council. The Council shall have one Convener, who shall concurrently serve as the Premier of the Executive Yuan, and several members appointed or designated by the Premier from among Ministers without Portfolio, heads of relevant agencies, and experts or scholars with experience in cancer prevention and control. The Council shall convene at least once a year.
Article 7
To ensure implementation of the national cancer control policy, the central competent authority shall establish a Cancer Control Policy Committee, with the following responsibilities:
1. Formulating cancer prevention and control policies;
2. Evaluating budgets for cancer control initiatives;
3. Assessing the performance of cancer control centers;
4. Establishing quality indicators for cancer prevention and control services provided by medical institutions;
5. Reviewing medical manpower, equipment, and programs related to cancer control;
6. Reviewing clinical practice guidelines for cancer diagnosis and treatment;
7. Reviewing cancer screening programs;
8. Addressing other cancer control-related matters.
The Committee shall consult relevant experts, industry stakeholders, cancer patients, and representatives of their families when executing its duties.
1. Formulating cancer prevention and control policies;
2. Evaluating budgets for cancer control initiatives;
3. Assessing the performance of cancer control centers;
4. Establishing quality indicators for cancer prevention and control services provided by medical institutions;
5. Reviewing medical manpower, equipment, and programs related to cancer control;
6. Reviewing clinical practice guidelines for cancer diagnosis and treatment;
7. Reviewing cancer screening programs;
8. Addressing other cancer control-related matters.
The Committee shall consult relevant experts, industry stakeholders, cancer patients, and representatives of their families when executing its duties.
Article 8
The Minister of Health and Welfare shall serve as the Convener of the Cancer Control Policy Committee. The Committee shall consist of 18 to 24 unpaid members, including:
1. A representative from the National Health Research Institutes;
2. A representative from the National Science and Technology Council;
3. Representatives from medical colleges and universities;
4. Experts and scholars in public health, cancer researchers, medical association representatives, and physicians specializing in pathology, oncology, and radiation oncology, as well as other related experts and specialists;
5. Individuals of social credibility and representatives from civil organizations.
The members described in Items (3) to (5) shall be appointed by the Convener for a two-year term and may be reappointed. The members under Items (4) and (5) shall constitute no less than one-half of the total membership. No single gender shall constitute less than one-third of the total membership.
The Committee shall convene at least once every quarter, and ad hoc meetings may be convened by the Convener when necessary, all of which shall be called by the Convener.
1. A representative from the National Health Research Institutes;
2. A representative from the National Science and Technology Council;
3. Representatives from medical colleges and universities;
4. Experts and scholars in public health, cancer researchers, medical association representatives, and physicians specializing in pathology, oncology, and radiation oncology, as well as other related experts and specialists;
5. Individuals of social credibility and representatives from civil organizations.
The members described in Items (3) to (5) shall be appointed by the Convener for a two-year term and may be reappointed. The members under Items (4) and (5) shall constitute no less than one-half of the total membership. No single gender shall constitute less than one-third of the total membership.
The Committee shall convene at least once every quarter, and ad hoc meetings may be convened by the Convener when necessary, all of which shall be called by the Convener.
Article 9
The central competent authority may integrate cancer screening and treatment institutions to establish comprehensive regional cancer screening and treatment service networks. It may also, as needed, provide subsidies to establish cancer control centers and support medical institutions in implementing cancer prevention and control services. Cancer control centers shall, in accordance with the resolutions of the Cancer Control Policy Committee, carry out the following responsibilities:
1. Promoting cancer education and screening programs;
2. Diagnosing and treating cancer patients based on clinical practice guidelines;
3. Providing follow-up care plans for cancer patients;
4. Delivering integrated palliative care services for patients and their families;
5. Establishing cancer-related databases;
6. Establishing referral service networks;
7. Providing training for medical personnel involved in cancer prevention and control;
8. Implementing cancer diagnosis and treatment quality assurance programs;
9. Actively Ppromoting community-based cancer prevention and control programs through the integration of community resources.
1. Promoting cancer education and screening programs;
2. Diagnosing and treating cancer patients based on clinical practice guidelines;
3. Providing follow-up care plans for cancer patients;
4. Delivering integrated palliative care services for patients and their families;
5. Establishing cancer-related databases;
6. Establishing referral service networks;
7. Providing training for medical personnel involved in cancer prevention and control;
8. Implementing cancer diagnosis and treatment quality assurance programs;
9. Actively Ppromoting community-based cancer prevention and control programs through the integration of community resources.
Article 10
The National Health Research Institutes shall establish a Cancer Research Center to coordinate and conduct research on cancer-related topics, including treatment methods, diagnostic technologies, pharmaceuticals, and clinical trials.
Article 11
To establish cancer-related databases, cancer control medical institutions shall submit the following data to academic research institutions commissioned by the central competent authority:
1. Data on newly diagnosed cancer cases, including staging, diagnosis, and treatment information;
2. Follow-up diagnostic and treatment data for individuals with positive cancer screening results;
3. Data on cancer cases confirmed through pathological examination, or presumptively diagnosed through other valid diagnostic
methods;
4. Cancer-related mortality data;
5. Other data required for the promotion of cancer prevention and control.
The regulations governing the deadlines, formats, reimbursement to reporting institutions, and other compliance matters shall be prescribed by the central competent authority.
1. Data on newly diagnosed cancer cases, including staging, diagnosis, and treatment information;
2. Follow-up diagnostic and treatment data for individuals with positive cancer screening results;
3. Data on cancer cases confirmed through pathological examination, or presumptively diagnosed through other valid diagnostic
methods;
4. Cancer-related mortality data;
5. Other data required for the promotion of cancer prevention and control.
The regulations governing the deadlines, formats, reimbursement to reporting institutions, and other compliance matters shall be prescribed by the central competent authority.
Article 12
Institutions receiving data under Article 11 shall designate personnel to implement security measures in accordance with relevant laws, in order to prevent unauthorized access, alteration, damage, or loss of personal data.
Article 13
The competent authority may, as needed, conduct cancer prevention and screening programs for the public. The expenses may be funded by allocations from the Tobacco Health and Welfare Surcharge or by donations from organizations or groups.
Article 14
Cancer screening medical institutions shall proactively urge individuals with precancerous conditions or positive screening results to return for diagnostic confirmation or for referral to appropriate care.
Article 15
Cancer control medical institutions shall establish internal cancer care quality assurance teams to ensure the quality of cancer screening, diagnosis, and treatment services. The central competent authority shall formulate guidelines for these quality assurance measures in consultation with relevant experts and scholars.
Article 16
The State shall allocate sufficient manpower and financial resources to ensure the effective promotion of cancer prevention and control initiatives.
Article 17
Institutions that, after being ordered by the competent authority to submit data under Article 11, Paragraph 1 within a specified deadline, fails to do so by the deadline shall be subject to a fine of not less than NT$10,000 and not more than NT$50,000. Institutions that violat Article 12 shall be subject to a fine of not less than NT$100,000 and not more than NT$500,000.
The fines set forth in the preceding two paragraphs shall be imposed by the central competent authority.
The fines set forth in the preceding two paragraphs shall be imposed by the central competent authority.
Article 18
This Act shall enter into force on the date of promulgation.